61 related articles for article (PubMed ID: 38732837)
1. Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patients.
Belnour S; Slater R; Tharmaratnam K; Karl-Heinz Auth M; Muhammed R; Spray C; Wang D; Zeeshan Ijaz U; Probert C; Allen S
United European Gastroenterol J; 2024 Jun; ():. PubMed ID: 38922802
[TBL] [Abstract][Full Text] [Related]
2. Short-chain fatty acid levels in stools of patients with inflammatory bowel disease are lower than those in healthy subjects.
Ozturk O; Celebi G; Duman UG; Kupcuk E; Uyanik M; Sertoglu E
Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):890-896. PubMed ID: 38829943
[TBL] [Abstract][Full Text] [Related]
3. Wake up and smell the coffee: The potential of faecal volatile organic compounds in paediatric inflammatory bowel disease.
Vermeer E; de Boer NKH; de Meij TGJ
United European Gastroenterol J; 2024 Jun; ():. PubMed ID: 38888204
[No Abstract] [Full Text] [Related]
4. Novel pharmacological developments in the management of paediatric inflammatory bowel disease.
Grover Z; Day AS
J Paediatr Child Health; 2024 Jun; ():. PubMed ID: 38923605
[No Abstract] [Full Text] [Related]
5. Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
Boon GJ; Day AS; Mulder CJ; Gearry RB
World J Gastroenterol; 2015 Oct; 21(40):11469-80. PubMed ID: 26523111
[TBL] [Abstract][Full Text] [Related]
6. Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome.
Fitzgerald RS; Sanderson IR; Claesson MJ
Microb Ecol; 2021 Nov; 82(4):833-844. PubMed ID: 33666710
[TBL] [Abstract][Full Text] [Related]
7. Faecal Volatile Organic Compound Analysis in De Novo Paediatric Inflammatory Bowel Disease by Gas Chromatography-Ion Mobility Spectrometry: A Case-Control Study.
Vermeer E; Jagt JZ; Stewart TK; Covington JA; Struys EA; de Jonge R; de Boer NKH; de Meij TGJ
Sensors (Basel); 2024 Apr; 24(9):. PubMed ID: 38732837
[TBL] [Abstract][Full Text] [Related]
8. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
[TBL] [Abstract][Full Text] [Related]
9. The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis.
Bosch S; Wintjens DSJ; Wicaksono A; Kuijvenhoven J; van der Hulst R; Stokkers P; Daulton E; Pierik MJ; Covington JA; de Meij TGJ; de Boer NKH
Dig Liver Dis; 2020 Jul; 52(7):745-752. PubMed ID: 32402741
[TBL] [Abstract][Full Text] [Related]
10. Optimized Sampling Conditions for Fecal Volatile Organic Compound Analysis by Means of Field Asymmetric Ion Mobility Spectrometry.
Bosch S; El Manouni El Hassani S; Covington JA; Wicaksono AN; Bomers MK; Benninga MA; Mulder CJJ; de Boer NKH; de Meij TGJ
Anal Chem; 2018 Jul; 90(13):7972-7981. PubMed ID: 29860824
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD).
Arasaradnam RP; McFarlane M; Daulton E; Skinner J; O'Connell N; Wurie S; Chambers S; Nwokolo C; Bardhan K; Savage R; Covington J
Dig Liver Dis; 2016 Feb; 48(2):148-53. PubMed ID: 26682719
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD.
El Manouni El Hassani S; Bosch S; Lemmen JPM; Brizzio Brentar M; Ayada I; Wicaksono AN; Covington JA; Benninga MA; de Boer NKH; de Meij TGJ
Sensors (Basel); 2019 Oct; 19(20):. PubMed ID: 31623289
[TBL] [Abstract][Full Text] [Related]
13. Volatile organic compounds as potential biomarkers of irritable bowel syndrome: A systematic review.
Zhang VR; Ramachandran GK; Loo EXL; Soh AYS; Yong WP; Siah KTH
Neurogastroenterol Motil; 2023 Jul; 35(7):e14536. PubMed ID: 36780514
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent.
Bosch S; Wintjens DSJ; Wicaksono A; Pierik M; Covington JA; de Meij TGJ; de Boer NKH
Sensors (Basel); 2022 Mar; 22(6):. PubMed ID: 35336485
[TBL] [Abstract][Full Text] [Related]
15. IBD metabonomics predicts phenotype, disease course, and treatment response.
Bjerrum JT; Wang YL; Seidelin JB; Nielsen OH
EBioMedicine; 2021 Sep; 71():103551. PubMed ID: 34419930
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
